06:47 EST Lilly says Zepbound superior to Novo’s Wegovy weight loss in head-to-head trial
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Truist biopharma analyst to hold an analyst/industry conference call
- S&P 500 Slips after October’s Jobs Report
- Eli Lilly downgraded to Hold from Buy at Erste Group
- RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule
- Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz